Product Name: Noveltreat™ Semaglutide Solution for Injection Active Ingredient: Semaglutide Strength: 0.25 mg Dosage Form: Solution for Injection Presentation: Prefilled Pen Pack Size: 2 Single-Dose Prefilled Pens Volume: 0.5 mL per pen Route of Administration: Subcutaneous Therapeutic Category: GLP-1 Receptor Agonist Product Description Noveltreat™ Semaglutide Solution for Injection 0.25 mg is a semaglutide-based injectable pharmaceutical product supplied in a prefilled-pen format. The product is intended for use under the supervision of a qualified healthcare professional and according to the approved prescribing information applicable in the destination market. The 0.25 mg strength may be used as part of an initial treatment regimen where specifically indicated by the relevant product information. Key Product Features Semaglutide-based injectable formulation 0.25 mg strength Convenient prefilled-pen presentation Single-dose pen format Subcutaneous administration Suitable for pharmaceutical sourcing and export inquiries, subject to applicable regulations Commonly Associated Therapeutic Uses Semaglutide products may be approved for specific diabetes and/or weight-management indications depending on the product and country. Always verify the approved indication for the exact product in the destination country before use or distribution. Storage & Handling Store and handle the product strictly according to the manufacturer's official packaging and prescribing information. Temperature requirements can be important for injectable medicines, particularly during pharmaceutical transportation. International Pharmaceutical Export MEDINDIA EXPORT provides international medicine-export and pharmaceutical sourcing support for eligible destinations. International orders may be subject to: Import regulations Prescription requirements Product registration Customs clearance Import permits Destination-country pharmaceutical laws Cold-chain or transportation requirements where applicable Availability and export eligibility should be confirmed before ordering. Trading FAQs Q1. What is Noveltreat Semaglutide 0.25 mg? Noveltreat is a semaglutide-containing injectable product supplied in a 0.25 mg prefilled-pen presentation. Q2. What is the pack size? The displayed presentation contains 2 single-dose prefilled pens, each indicated as 0.25 mg/0.5 mL. Q3. How is the product administered? It is intended for subcutaneous administration according to the applicable prescribing information. Q4. Is Noveltreat available for international export? Export availability depends on destination-country regulations, product availability and required import permissions. Q5. Can I purchase this product for resale? Commercial distribution must comply with the pharmaceutical and import regulations applicable in the destination market. Q6. Does MEDINDIA EXPORT support international buyers? Yes. We accept pharmaceutical sourcing and export inquiries for eligible international destinations. Request a Catalogue / Trade Inquiry For Noveltreat™ Semaglutide 0.25 mg availability, pricing, packing details and international trade inquiries, contact: 🌐 Website: www.medicineindiaexport.com 📧 Email: sales.medindiaexport@gmail.com 📱 WhatsApp: +91 7218129896 MEDINDIA EXPORT – International Medicine Export & Pharmaceutical Sourcing
Nagpur, Maharashtra, India, India, 440024